Comparative investigation of protective effects of metyrosine and metoprolol against ketamine cardiotoxicity in rats

Göster/ Aç
Erişim
info:eu-repo/semantics/closedAccessTarih
2015Yazar
Ahıskalıoğlu, Aliİnce, İlker
Aksoy, Mehmet
Ahıskalıoğlu, Elif Oral
Çömez, Mehmet
Dostbil, Ayşenur
Çelik, Mine
Alp, Hamit Hakan
Coşkun, Reşit
Taghizadehghalehjoughi, Ali
Süleyman, Bahadır
Üst veri
Tüm öğe kaydını gösterKünye
Ahiskalioglu, A., Ince, I., Aksoy, M., Ahiskalioglu, E. O., Comez, M., Dostbil, A., Celik, M., Alp, H. H., Coskun, R., Taghizadehghalehjoughi, A., & Suleyman, B. (2015). Comparative Investigation of Protective Effects of Metyrosine and Metoprolol Against Ketamine Cardiotoxicity in Rats. Cardiovascular toxicology, 15(4), 336–344. https://doi.org/10.1007/s12012-014-9301-zÖzet
This study investigated the effect of metyrosine against ketamine-induced cardiotoxicity in rats and compared the results with the effect of metoprolol. in this study, rats were divided into groups A, B and C. in group A, we investigated the effects of a single dose of metyrosine (150 mg/kg) and metoprolol (20 mg/kg) on single dose ketamine (60 mg/kg)-induced cardiotoxicity. in group B, we investigated the effect of metyrosine and metoprolol, which were given together with ketamine for 30 days. in group C, we investigated the effect of metyrosine and metoprolol given 15 days before ketamine and 30 days together with ketamine on ketamine cardiotoxicity. By the end of this process, we evaluated the effects of the levels of oxidant-antioxidant parameters such as MDA, MPO, 8-OHGua, tGSH, and SOD in addition to CK-MB and TP I on cardiotoxicity in rat heart tissue. the experimental results show that metyrosine prevented ketamine cardiotoxicity in groups A, B and C and metoprolol prevented it in only group C.